✦ LIBER ✦

Clinical Trial Design in Small Cell Lung Cancer: Surrogate End Points and Statistical Evolution

✍ Scribed by Nickolich, Myles; Babakoohi, Shahab; Fu, Pingfu; Dowlati, Afshin

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Optimizing Surrogate End Points for Preo

✍ William, William N.; Swisher, Stephen G. 📂 Article 📅 2014 🏛 Springer 🌐 English ⚖ 157 KB

The use of expert surrogates to evaluate

📂 Article 📅 1987 🏛 Elsevier Science 🌐 English ⚖ 126 KB

Surrogate end points for survival in the

✍ Xiaoqin Li, Shan Liu, Hangang Gu, Deqiang Wang 📂 Article 📅 2012 🏛 Springer-Verlag 🌐 English ⚖ 372 KB

Clinical Development of Gefitinib in Non

✍ Nancy Price; Chandra P. Belani 📂 Article 📅 2005 🏛 CIG Media Group, LP. 🌐 English ⚖ 86 KB

Clinical trial experience with Functiona

✍ Anne Heyes 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 116 KB

Vaccines in non-small cell lung cancer:

✍ Tommaso De Pas; Monica Giovannini; Maria Rescigno; Chiara Catania; Francesca Tof 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 434 KB